GSK plc Form 6-K Filing Summary

2026-07-14SEC Filing 6-K (0001654954-26-006640)

This report details transactions related to GSK plc ordinary shares and American Depositary Shares (ADSs) by various PDMRs (PDMR/person closely associated with them) occurring on July 9th and July 10th, 2026. These transactions primarily involve the acquisition of shares/ADSs through the reinvestment of dividends. Specific individuals like Luke Miels, Lynn Baxter, Mike Crichton, James Ford, Nina Mojas, David Redfern, Regis Simard, Philip Thomson, Deborah Waterhouse, Tony Wood, and Neil Falkingham are listed, along with their respective positions and the details of their share acquisitions. The transactions were conducted on the London Stock Exchange (XLON) and the New York Stock Exchange (XNYS) at prices ranging from Β£19.5950 to Β£19.7550 for ordinary shares and $52.4700 for ADSs. Some transactions also involved increases in notional interest in shares/ADSs held within the Company's Deferred Annual Bonus Plan.

Ticker mentioned:GSK